Eladocagene exuparvovec, the only gene therapy for children with the ultra-rare genetic disorder, aromatic L-amino acid decarboxylase (AADC) deficiency, has been recommended by the National Institute for Health and Care Excellence (NICE).
It is estimated that there are only ten UK-based children with the ultra-rare condition and a small number of these individuals may be eligible for the therapy…
